|4Apr 20, 4:05 PM ET

Bjarke Henric Bjorn 4

4 · Inozyme Pharma, Inc. · Filed Apr 20, 2022

Insider Transaction Report

Form 4
Period: 2022-04-19
Transactions
  • Purchase

    Common Stock

    2022-04-19$3.69/sh+27,100$99,99980,626 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION